Found 0 matching trials
An Extension Study Evaluating Safety and Efficacy of Proellex® In Women Who Have Previously Completed ZPU 003 Ext PHASE2 An open label, extension study for subjects completing the ZPU-003 Ext 1 st...
Show More Location
Advances in Health, Inc.
Learn More & Join Trial
Evaluation of Safety, Pharmacokinetics, and Efficacy of Proellex Administered Vaginally in Women With Uterine Fibroids PHASE2 To determine the safety, pharmacokinetics and efficacy of 4 doses (3, 6, 12...
Show More Learn More & Join Trial
Evaluate PK and Safety of Proellex® in Females With Various Stages of Impaired Renal Function and Healthy Females PHASE1 PK and safety profile of Proellex® in females with various stages of impair...
Show More Location
Clinical Pharmacology of Miami, Inc
Learn More & Join Trial
Evaluating the Safety and Efficacy of Proellex® in Premenopausal Women With Symptomatic Uterine Fibroids PHASE3 Premenopausal women with symptomatic uterine fibroids will be randomized to...
Show More Location
Advanced Clinical Research Institute
Learn More & Join Trial
Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids PHASE3 The safety of Proellex 25 and 50 mg administered once daily for three treat...
Show More Location
Lynn Institute of the Ozarks
Learn More & Join Trial
Safety and Efficacy of 25 and 50 mg Doses of Proellex® in Treating the Recurrence of Uterine Fibroid Symptoms PHASE3 Subjects with symptomatic uterine fibroids will be enrolled and will receiv...
Show More Location
Genesis Center for Clinical Research
Learn More & Join Trial
Determination of the Lowest, Safe and Effective Dose of Proellex PHASE1 The purpose of this study is to determine the effects of five different dos...
Show More Location
ICON Devlopment Solutions
Learn More & Join Trial
An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids PHASE2 To determine the safety of extended treatment with Proellex® in women who h...
Show More Location
KO Clinical Research, LLC
Learn More & Join Trial
Evaluate the Safety and PK of Proellex® in Female Patients With Impaired Hepatic Function and Healthy Adults PHASE1 This study will evaluate the safety and pharmacokinetics of two doses of or...
Show More Location
Clinical Pharmacology of Miami, Inc.
Learn More & Join Trial
Open-Label, Multiple-Dose, Non-Randomized Study to Assess Drug-Drug Interactions of Proellex® in Female Subjects PHASE1 This study will assess possible drug-drug interactions with specific isoenz...
Show More Location
Clinical Research Center Advanced Biomedical Research Inc.
Learn More & Join Trial